Company News, Regulations

Company Cited for COVID-19 Claims

Mouth rinse claims catch eye of FDA and FTC.

Rowpar Pharmaceuticals, Scottsdale, AZ, has been issued a warning letter following after the FDA and Federal Trade Commission (FTC) reviewed its website on October 22, 2020, and December 7, 2020, respectively as well as on its Facebook and Twitter pages.   The FDA has observed that your website offers CloSYS Oral Spray, CloSYS Non-Irritating Rinse Un-flavored for Ultra Sensitive Mouths, and CloSYS Non-Irritating Rinse Mildly Flavored for Sensitive Mouths products for sale in the US and that th...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters